Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Daily Top 10 COVID-19 publications

Deutsch | English | Español | Français | Italiano | Português; | Tiếng Việt | Türkçe


  Multiple Sclerosis

  Free Subscription


Articles published in Int J Neurosci

Retrieve available abstracts of 22 articles:
HTML format



Single Articles


    April 2020
  1. MOUSAVI-SHIRAZI-FARD Z, Mazloom Z, Izadi S, Fararouei M, et al
    The effects of modified anti-inflammatory diet on fatigue, quality of life,and inflammatory biomarkers in relapsing-remitting multiple sclerosis patients: A randomized clinical trial.
    Int J Neurosci. 2020 Apr 6:1-12. doi: 10.1080/00207454.2020.1750398.
    PubMed     Abstract available


    February 2020
  2. JAMEBOZORGI K, Rostami D, Pormasoumi H, Taghizadeh E, et al
    Epigenetic aspects of multiple sclerosis and future therapeutic options.
    Int J Neurosci. 2020 Feb 20:1-15. doi: 10.1080/00207454.2020.1732974.
    PubMed     Abstract available


  3. MEUTH SG, Henze T, Essner U, Trompke C, et al
    Tetrahydrocannabinol and cannabidiol oromucosal spray in resistant multiple sclerosis spasticity: consistency of response across subgroups from the SAVANT randomized clinical trial.
    Int J Neurosci. 2020 Feb 17:1-15. doi: 10.1080/00207454.2020.1730832.
    PubMed     Abstract available


    December 2019
  4. JAFARINIA M, Sadeghi E, Alsahebfosoul F, Etemadifar M, et al
    Evaluation of plasma Osteopontin level in relapsing- remitting multiple sclerosis patients compared to healthy subjects in Isfahan Province.
    Int J Neurosci. 2019 Dec 3:1-6. doi: 10.1080/00207454.2019.1694925.
    PubMed     Abstract available


  5. SHAKER OG, Golam RM, Ayoub S, Daker LI, et al
    Correlation between LincR-Gng2-5'and LincR-Epas1-3'as with the severity of multiple sclerosis in Egyptian patients.
    Int J Neurosci. 2019 Dec 2:1-7. doi: 10.1080/00207454.2019.1695610.
    PubMed     Abstract available


  6. RAJIZADEH MA, Sheibani V, Bejeshk MA, Mohtashami Borzadaran F, et al
    The effects of high intensity exercise on learning and memory impairments followed by combination of sleep deprivation and demyelination induced by etidium bromide.
    Int J Neurosci. 2019;129:1166-1178.
    PubMed     Abstract available


    November 2019
  7. MORADI M, Gharesouran J, Ghafouri-Fard S, Noroozi R, et al
    Role of NR3C1 and GAS5 genes polymorphisms in Multiple Sclerosis.
    Int J Neurosci. 2019 Nov 14:1-10. doi: 10.1080/00207454.2019.1694019.
    PubMed     Abstract available


    October 2019
  8. TOBORE TO
    Towards a Comprehensive Etiopathogenetic and Pathophysiological Theory of Multiple Sclerosis.
    Int J Neurosci. 2019 Oct 7:1-41. doi: 10.1080/00207454.2019.1677648.
    PubMed     Abstract available


    September 2019
  9. EFTEKHARIAN MM, Taheri M, Arsang-Jang S, Komaki A, et al
    Nicotinamide nucleotide transhydrogenase expression analysis in multiple sclerosis patients.
    Int J Neurosci. 2019 Sep 2:1-5. doi: 10.1080/00207454.2019.1660655.
    PubMed     Abstract available


    March 2019
  10. HALICIOGLU S, Turkoglu SA
    Role of developmental venous anomalies in etiopathogenesis of demyelinating diseases.
    Int J Neurosci. 2019;129:245-251.
    PubMed     Abstract available


    January 2019
  11. DOGAN U, Ulas F, Aydin Turkoglu S, Nur Ogun M, et al
    Eyes are Mirror of the Brain: Comparison of Multiple Sclerosis Patients and Healthy Controls Using OCT.
    Int J Neurosci. 2019 Jan 29:1-9. doi: 10.1080/00207454.2019.1576660.
    PubMed     Abstract available


    October 2018
  12. SHAHEEN HA, Sayed SS, Daker LI, AbdelAziz HE, et al
    Does vitamin D deficiency predict early conversion of clinically isolated syndrome? A preliminary Egyptian study.
    Int J Neurosci. 2018;128:946-951.
    PubMed     Abstract available


    August 2018
  13. JAHANBANI-ARDAKANI H, Alsahebfosoul F, Moshfeghi SR, Mahaki B, et al
    Serum level of Interleukin 12 in patients with multiple sclerosis.
    Int J Neurosci. 2018 Aug 8:1-7. doi: 10.1080/00207454.2018.1504782.
    PubMed    


    May 2018
  14. MARKOVA J, Essner U, Akmaz B, Marinelli M, et al
    Sativex(R) as Add-on therapy Vs. further optimized first-line ANTispastics (SAVANT) in resistant multiple sclerosis spasticity: a double-blind, placebo-controlled randomised clinical trial.
    Int J Neurosci. 2018 May 24:1-26. doi: 10.1080/00207454.2018.1481066.
    PubMed     Abstract available


    January 2018
  15. FAHMY EM, Elfayoumy NM, Abdelalim AM, Sharaf SA, et al
    Relation of serum levels of homocysteine, vitamin B12 and folate to cognitive functions in multiple sclerosis patients.
    Int J Neurosci. 2018 Jan 31:1-23. doi: 10.1080/00207454.2018.1435538.
    PubMed     Abstract available


  16. LI LM, Guo HY, Zhao N, Zhang LJ, et al
    Comparison of olfactory function between neuromyelitis optica and multiple sclerosis.
    Int J Neurosci. 2018 Jan 3:1-21. doi: 10.1080/00207454.2018.1424152.
    PubMed     Abstract available


    October 2017
  17. ABDOLLAH ZADEH R, Moradi Pordanjani P, Rahmani F, Mashayekhi F, et al
    Association of VDR gene polymorphisms with risk of Relapsing-remitting multiple sclerosis in an Iranian Kurdish population.
    Int J Neurosci. 2017 Oct 26:1-17. doi: 10.1080/00207454.2017.1398158.
    PubMed     Abstract available


    January 2017
  18. KIM G, Chu R, Yousuf F, Tauhid S, et al
    Sample size requirements for one-year treatment effects using deep gray matter volume from 3T MRI in progressive forms of multiple sclerosis.
    Int J Neurosci. 2017 Jan 19:1-34. doi: 10.1080/00207454.2017.1283313.
    PubMed     Abstract available


    December 2016
  19. DAHDALEH M, Alroughani R, Aljumah M, AlTahan A, et al
    Intervening to reduce the risk of future disability from multiple sclerosis: are we there yet?
    Int J Neurosci. 2016 Dec 28:1-16. doi: 10.1080/00207454.2016.1277424.
    PubMed     Abstract available


  20. LASEK-BAL A, Bartoszek K, Steposz A, Puz P, et al
    Efficacy and safety of mitoxantrone use in primary and secondary progressive multiple sclerosis - study site experience based on the therapy of 104 patients.
    Int J Neurosci. 2016.
    PubMed     Abstract available


    November 2016
  21. GAO C, Wu L, Chen X, Long Y, et al
    Hypothalamic abnormality in patients with inflammatory demyelinating disorders.
    Int J Neurosci. 2016;126:1036-43.
    PubMed     Abstract available


    September 2016
  22. JAMROZ-WISNIEWSKA A, Beltowski J, Bartosik-Psujek H, Wojcicka G, et al
    Processes of plasma protein N-homocysteinylation in multiple sclerosis.
    Int J Neurosci. 2016.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Multiple Sclerosis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: